LSI is Officially Heading to Singapore — Register for LSI Asia '25 Today

Exosome Diagnostics (Acquired)

Proprietary technology focused on rapid, robust isolation of clinically actionable genetic biomarkers from blood, urine and cerebrospinal fluid for di....

Get a Demo and See the Full Profile

Get a demo today to see profiles of Exosome Diagnostics (Acquired) plus 6131 other startups.

Learn More About Exosome Diagnostics (Acquired)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups

More